China's Medical Service Pricing Reform: Impact on Innovative Medical Technology Pricing and Adoption
Presented by: NRDL+ Executive Debrief
Stay ahead of value-based approval and pricing trends for medical services and discover strategic growth opportunities to support clinical and commercial strategies for innovative medical technologies in China.
MedTech companies are accelerating innovation in China, where public hospitals play a pivotal role. These hospitals employ 64% of licensed doctors, manage 82% of inpatient admissions, and handle 40% of ambulatory visits, accounting for nearly half of the country's total health expenditure.
This central role also contributes to China's unique approach to regulating medical service prices. Unlike many developed markets, public hospitals in China must adhere to the provincial medical service price catalog in order to offer and bill for treatments. While private hospitals have more flexibility to set their own prices, they often align with these standards to qualify as BMI-designated institutions and remain competitive.
For new technologies that fill clinical gaps, simplify complex procedures, or offer innovative treatments, securing a spot in a provincial medical service price catalog with optimized pricing is critical for success in China’s inpatient and outpatient markets.
In this course, you'll learn how China's medical service pricing reform affects the pricing and commercialization of innovative medical technologies. You’ll stay ahead of value-based approval and pricing trends, uncover strategic growth opportunities, and access practical planning guides and provincial policy summaries. These resources will help you strengthen your policy monitoring and implementation and support your clinical and commercial strategy development.
Upon completing this course, you will:
Course Syllabus:
Section One: Medical Service Pricing Governance and Management in China
Section Two: Key Focus Areas in China’s Medical Service Pricing Reform – Impact on Innovative Device Commercialization
Section Three: Provincial Trends in Value-Based Approval and Pricing for New Medical Services in China: MedTech’s Strategy
Frequently Asked Questions
Do you offer volume discounts for companies purchasing multiple licenses?
Yes, we do. Please reach out to us for more details.
What if I have questions after completing the course?
If you need further assistance or personalized support, feel free to contact us.
What is your refund policy?
Unfortunately, we do not offer refunds.